1-3 of 3
Emily Curran
Close
Sort by
Journal Articles

Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation

Clinical Trials & Observations
James Godfrey, Hongtao Liu, Jovian Yu, Michael Tallarico, Emily Curran, Andrew Artz, Peter A. Riedell, Wendy Stock, Theodore Karrison, Carrie Fitzpatrick, Girish Venkataraman, Alan Cooper, Sonali M. Smith, Michael R. Bishop, Justin Kline
Journal: Blood Advances
Blood Adv (2023) 7 (6): 963–970.
https://doi.org/10.1182/bloodadvances.2022008403
Published: 2023
Includes: Supplemental data
Journal Articles

Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia

Punita Grover, Olivier Veilleux, Lu Tian, Ryan Sun, Melissa Previtera, Emily Curran, Lori Muffly
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1608–1618.
https://doi.org/10.1182/bloodadvances.2020003482
Published: 2022
Includes: Supplemental data
Journal Articles

Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab

Clinical Trials & Observations
Talha Badar, Aniko Szabo, Anjali Advani, Martha Wadleigh, Shukaib Arslan, Muhammad Ali Khan, Ibrahim Aldoss, Caitlin Siebenaller, Elizabeth Schultz, Mehrdad Hefazi, Rory M. Shallis, Ilana Yurkiewicz, Nikolai Podoltsev, Anand A. Patel, Emily Curran, Suresh Balasubramanian, Jay Yang, Ryan J. Mattison, Madelyn Burkart, Shira Dinner, Michaela Liedtke, Mark R. Litzow, Ehab Atallah
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2308–2316.
https://doi.org/10.1182/bloodadvances.2019001381
Published: 2020
Includes: Supplemental data